Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cyclodextrins in drug delivery.

Thorsteinn Loftsson1, Pekka Jarho, Már Másson

  • 1University of Iceland, Faculty of Pharmacy, Hagi, Reykjavik. thorstlo@hi.is

Expert Opinion on Drug Delivery
|November 22, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chitosan-coated cyclodextrin-based niosomes enable enhanced nose-to-brain delivery of rivastigmine and asiaticoside for Alzheimer's disease.

International journal of biological macromolecules·2026
Same author

HATU Coupling for Fast, Efficient, and Selective N-acylation of chitosan: DoE-optimized synthesis of cationic antibacterial derivatives.

Carbohydrate polymers·2026
Same author

Cyclodextrin-Based Niosomal Delivery of Imatinib against A549 Nonsmall Cell Lung Cancer Cells.

ACS omega·2026
Same author

Eco-Friendly Activation of Silicone Surfaces and Antimicrobial Coating with Chitosan Biopolymer.

International journal of molecular sciences·2025
Same author

Cyclodextrin-based formulations for pediatric patients: pharmaceutical prospectives and toxicological evaluation.

The Journal of pharmacy and pharmacology·2025
Same author

The Chemical Stability Characterization and Kinetics of Statins in Aqueous Cyclodextrin Ocular Preparations: A Formulation Perspective.

Pharmaceutics·2025
Same journal

Dry powder inhaler selection in COPD: integrating device design, formulation performance, and patient inspiratory capability.

Expert opinion on drug delivery·2026
Same journal

Letter to the Editor: 'saving money but costing lives: the lack of integrated dose counters on pressurised metered dose inhalers'.

Expert opinion on drug delivery·2026
Same journal

Response to letter to the editor: 'Saving money but costing lives: the lack of integrated dose counters on pressurised metered dose inhalers'.

Expert opinion on drug delivery·2026
Same journal

Mechanism-guided metal complex therapeutics for biofilm-driven wound infections and transdermal delivery.

Expert opinion on drug delivery·2026
Same journal

Next-generation strategies for PROTAC formulation: mechanistic insights and advanced formulation technologies.

Expert opinion on drug delivery·2026
Same journal

Drug penetration in solid tumors: influence of drug size and capillary architecture.

Expert opinion on drug delivery·2026
See all related articles

Cyclodextrins, cyclic oligosaccharides, enhance drug solubility and bioavailability. Optimization is key for effective drug delivery formulations using these complexing agents.

Area of Science:

  • Pharmaceutical Sciences
  • Medicinal Chemistry
  • Drug Delivery

Background:

  • Cyclodextrins are cyclic oligosaccharides with distinct hydrophilic and lipophilic properties.
  • Their large size and hydrogen bonding capabilities limit lipophilic membrane permeation.
  • Primarily utilized in pharmaceuticals to improve solubility, bioavailability, and stability of drugs.

Purpose of the Study:

  • To explore the role and application of cyclodextrins in pharmaceutical formulations.
  • To highlight the benefits and challenges of using cyclodextrins for drug delivery.
  • To review the current market presence of cyclodextrin-based drug products.

Main Methods:

  • Literature review of cyclodextrin applications in drug formulation.
  • Analysis of studies investigating cyclodextrin effects in human and animal models.

Related Experiment Videos

  • Examination of existing pharmaceutical products containing cyclodextrin complexes.

    • Main Results:

    • Cyclodextrins significantly enhance aqueous solubility and bioavailability of poorly soluble drugs.
    • They can improve drug stability and delivery across various formulation types.
    • Successful integration requires formulation optimization beyond simple addition.

    Conclusions:

    • Cyclodextrins are valuable pharmaceutical excipients for improving drug properties.
    • Careful formulation design is essential for realizing their full therapeutic potential.
    • Approximately 30 marketed products demonstrate the commercial viability of cyclodextrin technology.